CAN1012 Combined With PD-1 in Patients With Solid Tumors — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CAN1012 Combined With PD-1 in Patients With Solid Tumors — Stella

Recruiting

Back to Advanced Solid Tumor trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

China

Sun Yat-Sen University Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong

Key details

Phase

Safety & dosing

Sponsor

Canwell Biotech Limited

Enrollment target

~71 participants

Started

June 2024

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov